ezogabine/retigabine

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Epilepsy

Phase 2

Study in Pediatric Subjects With Epilepsy

TerminatedNCT01494584

GlaxoSmithKlineEpilepsy

Start: 2012-07-25End: 2013-04-29Updated: 2020-11-30

Phase 4

An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures

TerminatedNCT01607346

GlaxoSmithKlineEpilepsy

Start: 2013-03-27End: 2016-11-16Updated: 2020-12-04

Related Papers

Adolescent Clinical Development of Ezogabine/Retigabine as Adjunctive Therapy for Partial-Onset Seizures: Pharmacokinetics and Tolerability

The Journal of Pediatric Pharmacology and Therapeutics2016-01-017 citations